USA

  Jiff, a Palo Alto, CA-based health technology company, raised $23.3M in its Series C funding round. The round was led by Rosemark Capital, with participation from GE Ventures, Venrock Associates, Aberdare Partners and Aeris Capital. In conjunction with the funding, GE Ventures’ Amy DuRoss, will join serve Jiff’s board as an observer. The company intends to use […]

USA

Butterfly Network, a Guilford, CT- and NYC-based based healthcare startup, raised over $100m in funding. Backers included Aeris Capital and Stanford University. Founded by Jonathan Rothberg, and a group of physicists and engineers from MIT, and Lincoln Laboratories’ through-wall radar team including Max Tegmark, Nevada Sanchez, Greg Charvat and Tyler Ralston, Butterfly Network aims to […]

USA

Jiff, a Palo Alto, CA-based digital health technology company, raised $18m in Series B funding. The round was led by Venrock, with participation from Aberdare Ventures and Aeris Capital. The company, which has raised $25.8m in venture capital since its founding, intends to use the funds to expand their sales and marketing team, to grow […]

USA

Smaato, a San Francisco, CA-based mobile real-time bidding ad exchange provider, closed a $25m Series E funding. Backers included Singapore Press Holdings Ltd, Aeris Capital, EDBI and other existing shareholders. The company will use the funds for operations and development of its platform. Led by Ragnar Kruse, CEO and co-founder, Smaato is a global mobile Real-Time Bidding (RTB) ad […]

fundingStart UpUSAventure capital

Invincea, Inc., a Fairfax, VA-based provider of advanced malware threat detection, breach prevention and forensic threat intelligence solutions, raised $16m in a Series C equity funding. The round was led by new investors Aeris Capital and Dell Ventures with participation from existing investors Grotech Ventures, Harbert Ventures, and New Atlantic Ventures. Additionally, the company announced […]

fundingGermanyventure capital

Affimed Therapeutics, a Heidelberg, Germany-based therapeutic TandAb antibody company, has closed a €15.5m (approximately $20m) Series D financing round. Backers include existing investors Aeris Capital, BioMedInvest, LSP Life Sciences Partners, Novo Nordisk A/S and Orbimed. Created as a spin-off from the German Cancer Research Centre (DKFZ), Heidelberg, and led by Dr. Adi Hoess, CEO, Affimed […]

fundingUSAventure capital

Jiff Inc., a Palo Alto, California-based developer of the first HIPAA-compliant private healthcare social network and digital health apps platform, has completed a $7.5m Series A financing. The round was led by Aeris Capital, with participation from founding seed investor Aberdare Ventures. The company intends to use the capital to deploy its healthcare social network, […]

Canadafundingventure capital

GenomeDx Biosciences Inc., a Vancouver, BC, Canada-based molecular diagnostic company, has closed a Series A financing round of undisclosed amount. The round was co-led by Baird Venture Partners and aeris CAPITAL, with participation from CD Ventures and individual investors. Led by CEO Doug Dolginow, M.D., GenomeDx develops molecular diagnostic tests and clinical support tools for […]

fundingUSAventure capital

Crescendo Bioscience, a South San Francisco, CA-based molecular diagnostics company developing quantitative biomarker tests for rheumatoid arthritis and other inflammatory diseases, has completed a $31m Series C equity financing and entered into a strategic investment agreement with Myriad Genetics for $25m, raising a total of $56m. The Series C round was led by aeris CAPITAL […]

fundingUSAventure capital

SynapSense Corp., a Folsom, Calif.-based provider of data center infrastructure management solutions, has closed a $16m Series C financing. The round was led by Crosslink Capital, with participation from Aeris Capital, Emerald Technology Ventures, GE Energy Financial Services, Nth Power, Robert Bosch Venture Capital and Sequoia Capital. The company intends to use the capital for product […]